Cargando…

A 2-month field cohort study of SARS-CoV-2 in saliva of BNT162b2 vaccinated nursing home workers

BACKGROUND: Nursing home (NH) residents have been severely affected during the COVID-19 pandemic because of their age and underlying comorbidities. Infection and outbreaks in NHs are most likely triggered by infected workers. Screening for asymptomatic NH workers can prevent risky contact and viral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saegerman, Claude, Diep, Anh Nguyet, Renault, Véronique, Donneau, Anne-Françoise, Stamatakis, Lambert, Coppieters, Wouter, Michel, Fabienne, Breuer, Christophe, Dandoy, Margaux, Ek, Olivier, Gourzones, Claire, Schyns, Joey, Goffin, Emeline, Minner, Frédéric, Durkin, Keith, Artesi, Maria, Bours, Vincent, Bureau, Fabrice, Gillet, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053279/ https://www.ncbi.nlm.nih.gov/pubmed/35603280 http://dx.doi.org/10.1038/s43856-021-00067-3

Ejemplares similares

University population-based prospective cohort study of SARS-CoV-2 infection and immunity (SARSSURV-ULiège): a study protocol
por: Donneau, Anne-Françoise, et al.
Publicado: (2022)

Compliance with Barrier Gestures during COVID-19 Pandemic as a Function of the Context: A Longitudinal Observational Survey at the University of Liège
por: Parisi, Gianni, et al.
Publicado: (2022)

The First Random Observational Survey of Barrier Gestures against COVID-19
por: Renault, Véronique, et al.
Publicado: (2021)

Acceptability of Community Saliva Testing in Controlling the COVID-19 Pandemic: Lessons Learned from Two Case Studies in Nursing Homes and Schools
por: Pétré, Benoit, et al.
Publicado: (2022)

Factors influencing the adoption and participation rate of nursing homes staff in a saliva testing screening programme for COVID-19
por: Pétré, Benoit, et al.
Publicado: (2022)

Development of a multiplex RT-qPCR using the drop out strategy to screen the SARS-CoV-2 South African 501Y.V2 variant
por: Maclot, François, et al.
Publicado: (2021)

Evaluation of Two Rapid Antigenic Tests for the Detection of SARS-CoV-2 in Nasopharyngeal Swabs
por: Seynaeve, Ysaline, et al.
Publicado: (2021)

A Recurrent Mutation at Position 26340 of SARS-CoV-2 Is Associated with Failure of the E Gene Quantitative Reverse Transcription-PCR Utilized in a Commercial Dual-Target Diagnostic Assay
por: Artesi, Maria, et al.
Publicado: (2020)

The Dynamic Relationship between the Intention and Final Decision for the COVID-19 Booster: A Study among Students and Staff at the University of Liège, Belgium
por: Paridans, Marine, et al.
Publicado: (2022)

A Single Oral Immunization with Replication-Competent Adenovirus-Vectored Vaccine Induces a Neutralizing Antibody Response in Mice against Canine Distemper Virus
por: Du, Xiang, et al.
Publicado: (2022)

Patients’ self-triage for unscheduled urgent care: a preliminary study on the accuracy and factors affecting the performance of a Belgian self-triage platform
por: Gilbert, Allison, et al.
Publicado: (2022)

Determinants of COVID-19 vaccine intention in a University population: a serial mediation approach
por: Paridans, M, et al.
Publicado: (2023)

Reconstruction of SARS-CoV-2 outbreaks in a primary school using epidemiological and genomic data
por: Kremer, Cécile, et al.
Publicado: (2023)

A systematic review of prediction models to diagnose COVID-19 in adults admitted to healthcare centers
por: Locquet, Médéa, et al.
Publicado: (2021)

Decision-based interactive model to determine re-opening conditions of a large university campus in Belgium during the first COVID-19 wave
por: Denoël, Vincent, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Genome Sequencing from Post-Mortem Formalin-Fixed, Paraffin-Embedded Lung Tissues
por: Van Campenhout, Claude, et al.
Publicado: (2021)

Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults
por: Robe, Pierre A, et al.
Publicado: (2009)

Clinical decision support tool for diagnosis of COVID-19 in hospitals
por: Saegerman, Claude, et al.
Publicado: (2021)

High response rate to BNT162b2 mRNA COVID-19 vaccine among self-care dialysis patients
por: Georgery, Hélène, et al.
Publicado: (2021)

Exploiting genomic surveillance to map the spatio-temporal dispersal of SARS-CoV-2 spike mutations in Belgium across 2020
por: Bollen, Nena, et al.
Publicado: (2021)

Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections
por: Desmecht, Salomé, et al.
Publicado: (2022)

Systematic Review of the Key Factors Influencing the Indoor Airborne Spread of SARS-CoV-2
por: de Crane D’Heysselaer, Simon, et al.
Publicado: (2023)

Training of radiotherapy professionals: status, content, satisfaction and improvement suggestions in the Greater Region
por: Dubois, Nadège, et al.
Publicado: (2022)

Factors Determining the Implementation of Measures Aimed at Preventing Zoonotic Diseases in Veterinary Practices
por: Renault, Véronique, et al.
Publicado: (2021)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

Clinical prediction models for diagnosis of COVID-19 among adult patients: a validation and agreement study
por: Dardenne, Nadia, et al.
Publicado: (2022)

Biosecurity Concept: Origins, Evolution and Perspectives
por: Renault, Véronique, et al.
Publicado: (2021)

Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies
por: Re, Daniel, et al.
Publicado: (2022)

Longitudinal Analysis of SARS-CoV-2-Specific Cellular and Humoral Immune Responses and Breakthrough Infection following BNT162b2/BNT162b2/BNT162b2 and ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naive Healthcare Workers
por: Ko, Geon Young, et al.
Publicado: (2023)

Lung Interstitial Macrophages: Past, Present, and Future
por: Schyns, Joey, et al.
Publicado: (2018)

SARS-CoV-2 Transmission in Belgian French-Speaking Primary Schools: An Epidemiological Pilot Study
por: Frère, Julie, et al.
Publicado: (2022)

A Phylodynamic Workflow to Rapidly Gain Insights into the Dispersal History and Dynamics of SARS-CoV-2 Lineages
por: Dellicour, Simon, et al.
Publicado: (2020)

Immune Responses After Vaccination With Primary 2-Dose ChAdOx1 Plus a Booster of BNT162b2 or Vaccination With Primary 2-Dose BNT162b2 Plus a Booster of BNT162b2 and the Occurrence of Omicron Breakthrough Infection
por: Choi, Seong-Ho, et al.
Publicado: (2023)

Neutralizing Activity of BNT162b2-Elicited Serum
por: Liu, Yang, et al.
Publicado: (2021)

BNT162b2 vaccine for prevention of COVID-19
Publicado: (2021)

Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022)

Erythema Multiforme after BNT162b2 Vaccination
por: Katayama, Sho, et al.
Publicado: (2022)

Pfizer SARS-CoV-2 BNT162b2 mRNA vaccination (BNT162b2) has no adverse effect on elective oocyte cryopreservation outcomes
por: Karavani, Gilad, et al.
Publicado: (2022)

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination
por: Lim, Xin Rong, et al.
Publicado: (2021)

SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
por: Falsey, Ann R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e9rpg717p1kdb1b1b844e0vuib